UNH vs CRL
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Charles River Laboratories International, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | CRL |
|---|---|---|
| Price | $418.09 | $345.37 |
| Market cap | $375.28B | $16.64B |
| P/E ratio | 26.9 | — |
| ROE | 15.77% | -7.52% |
| Profit margin | 3.53% | -5.96% |
| Revenue growth | -0.40% | -2.70% |
| Dividend yield | 2.22% | 0.00% |
| Beta | 0.61 | 1.40 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs CRL in plain English
- UNH is the bigger company — about 22.6× the market cap of CRL.
- UNH earns a higher return on equity (16% vs -8%).
- UNH is growing revenue faster (-0% vs -3%).
- UNH pays a dividend (2.22%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories International, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.